Clinical Trial Update: Study of LY3016859 in Participants With Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of LY3016859 in participants with diabetic nephropathy completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• LY3016859

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Nephropathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-15